- Custom synthesis of 14C labelled compounds to support pre-clinical ADME studies
- GMP synthesis of 14C labelled compounds for human AME studies
- Expertise and facilities for handling labelled gases and volatiles including Carbon Dioxide, Carbon Monoxide and Methyl Iodide.
Projects can be supported either by separate complete syntheses of non-clinical and clinical batches, or by synthesis of a pre-clinical intermediate, which can be used to prepare non-clinical and clinical batches. This second approach can avoid the need for a re-synthesis, saving both time and cost when providing labelled material for the hAME study.
CED Life ScienceThe CED Life Science Conference will be attended by Masha Kononov, Senior Director Emerging Pharma US and Gail Frey, Senior Director Key Accounts US.
CED Life ScienceDates: 26th - 27th FebruaryLocation: Raleigh, NC
Drug Delivery & Formulation SummitThe DDF Summit 2019 will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
Drug Delivery & Formulation SummitDates: 11th - 13th MarchLocation: Berlin, Germany
BioEurope SpringBioEurope Spring will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
BioEurope SpringDates: 25th - 27th MarchLocation: Vienna, Austria